GE HealthCare Technologies
GEHC | NASDAQ
$82.96
-$0.06 (-0.07%)
At close: Nov 16, 2026, 4:00 PM ET
$82.99
+$0.03 (+0.04%)
After-hours:
Nov 16, 2026, 7:36 PM ET
GE HealthCare Technologies Company Profile
Company profile explainedCompany Profile
GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
Key Executives
| Name | Position |
|---|---|
| Jeannette Bankes | President & Chief Executive Officer of Patient Care Solutions |
| Kevin Michael O'Neill | President & Chief Executive Officer of Pharmaceutical Diagnostics |
| Peter J. Arduini | President, Chief Executive Officer & Director |
| Adam Holton | Chief People Officer |
| Jahid Khandaker | Chief Information Officer |
| William K. Grogan | Chief Financial Officer |
| Carolynne Borders | Chief Investor Relations Officer |
| Catherine Estrampes | Chief Commercial & Growth Officer and Head of Global Markets |
| Frank R. Jimenez | General Counsel & Corporate Secretary |
| George Andrew Newcomb | Controller & Chief Accounting Officer |
| Rana Strellis | Chief Corporate Marketing & Communications Officer |
| Taha Kass-Hout | Chief Science & Technology Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 28, 2026 | 10-Q | Quarterly Report |
| Oct 28, 2026 | 8-K | Current Report |
| Sep 22, 2026 | 8-K | Current Report |
| Sep 16, 2026 | 4 | Filing |
| Sep 16, 2026 | 3 | Filing |
| Sep 04, 2026 | 4 | Filing |
| Sep 04, 2026 | 4 | Filing |
| Sep 04, 2026 | 4 | Filing |
| Sep 04, 2026 | 4 | Filing |
| Sep 04, 2026 | 4 | Filing |
GE HealthCare Technologies
| Country | United States |
| IPO Date | Dec 15, 2022 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 54,000 |
| CEO | Peter J. Arduini |
Contact Details
500 West Monroe Street Chicago,
Illinois 60661 United States
Stock Details
| Ticker Symbol | GEHC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001932393 |
| CUSIP Number | 36266G107 |
| ISIN Number | US36266G1076 |
| SIC Code | 3844 |
Recent News
- 13 hours ago / zacks.comGEHC or SYK: Which Is the Better Value Stock Right Now?
- 16 hours ago / gurufocus.comGE HealthCare expands global collaborations to help define the future of photon-counting CT with Photonova™ Spectra
- 3 days ago / zacks.comGE HealthCare Forms MAGNUS Neuro Alliance to Advance MRI Research
- 5 days ago / fool.comGE HealthCare: 3 Key Takeaways for Long-Term Investors
- 6 days ago / zacks.comGEHC Expands Vscan Air AI Capabilities With Lung Guidance & AutoAS
- 6 days ago / zacks.comGE HealthCare Technologies (GEHC) is a Top-Ranked Value Stock: Should You Buy?
- 6 days ago / businesswire.comGE HealthCare announces intent to establish MAGNUS Neuro Alliance to unlock new possibilities in MRI for neuroscience
- 12 days ago / zacks.comGE HealthCare Unveils Allia Celeo to Advance Interventional Imaging
- 13 days ago / zacks.comGEHC Q3 Earnings Call Highlights Raised Outlook and Margin Risks
- 16 days ago / gurufocus.comGE HealthCare debuts Allia Celeo, a ceiling-mounted interventional system designed for smooth procedural flow and AI-powered precision imaging
Add to Watchlist
Select watchlists to add or remove GEHC